Hope for Parkinson’s disease symptoms is found in late-stage drug study
Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...
AbbVie's Parkinson's disease drug meets main goal in late-stage study
AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...
Messenger News13 小时
Learn about effects, treatments for Parkinson’s disease
Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...
Ask the doctors: Parkinson’s disease can cause swolling issues
Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...
AbbVie's Parkinson's disease drug improves patient mobility in late-stage study
AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...
Scientists Identify Protein That Could Alleviate Parkinson’s Disease
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...
sciencex8 天
World-first clinical trial hopes to stop Parkinson's in its tracks
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
AbbVie's Early Parkinson's Candidate Hits Primary Goal In Pivotal Late-Stage Study
AbbVie Inc. (NYSE:ABBV) revealed topline results from its pivotal Phase 3 TEMPO-2 trial, which evaluated investigational ...
Daily1 天
Chronic musculoskeletal pain independently linked to incidence of Parkinson's disease: Study
A new study published in the journal of Movement Disorders showed that Parkinson's disease (PD) was found to be independently ...